首页 | 本学科首页   官方微博 | 高级检索  
     

卵磷脂络合碘治疗眼底疾病的临床验证
引用本文:刘武,王光璐. 卵磷脂络合碘治疗眼底疾病的临床验证[J]. 中国医药导刊, 2006, 8(6): 439-440
作者姓名:刘武  王光璐
作者单位:首都医科大学附属北京同仁医院眼科中心,北京,100730
摘    要:目的:验证卵磷脂络合碘(Lincorice-lecithin Bound Iodine,LBI)治疗玻璃体混浊、眼底出血和(或)渗出的有效性和安全性。方法:前瞻性研究跟底出血渗出及其所致玻璃体混浊者,非急性活动性炎症所致玻璃体混浊者连续服用LBI 1个月的效果。用药后第1、2个月复查,对用药前后眼底病变和视力进行分级评价。同时记录甲状腺等全身情况。结果:共有39例患者纳入和完成本验证研究,病因包括视网膜静脉阻塞等7种疾患。治疗总有效率92.31%。除1例用药后轻度不适外,均无全身其他不良反应发生。结论:LBI可有效治疗多种眼底疾病,使用方便,安全可靠,值得在临床推广使用。

关 键 词:卵磷脂络合碘  视网膜出血  玻璃体混浊
文章编号:1009-0959(2006)06-0439-02

Clinical Validation of Lincorice- lecithin Bound Iodine for Fundus Diseases
Liu Wu,Wang Guang-lu. Clinical Validation of Lincorice- lecithin Bound Iodine for Fundus Diseases[J]. Chinese Journal of Medicinal Guide, 2006, 8(6): 439-440
Authors:Liu Wu  Wang Guang-lu
Affiliation:Beijing Tong Ren Hospital Eye Center, Capital University of Medical Science, Beijing 100730, China
Abstract:Objective:To validate the efficacy and safety of Lincorice-lecithin Bound Iodine(LBI)for vitreous opacity,retinal hemorrhage and(or)exudation.Methods:A prospective trial was conducted to study the results of LBI taken orally for one month in pa- tients with fundus hemorrhage,exudation,and induced vitreous opacity in addition to inactive inflammation.Patients were followed at the 1st and 2nd month after the start of treatment,and their fundus situation and visual acuity were evaluated according to a scoring criteri- on.Thyroid and other systemic changes were also recorded.Results:39 patients were enrolled and completed the study,their etiology included retinal vascular occlusion and other 6 abnormalities.The total validity of the treatment was 92.31%.there was no systemic side effects excepts for one patient with mild discomfort.Conclusion:LBI maybe valid for a variety of fundus diseases,it was with conve- nience and safety,which deserves generalization.
Keywords:Lincorice-lecithin Bound Iodine  Retinal hemorrhage  Vitreous opacity  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号